| GTO ID | GTC4010 |
| Trial ID | NCT02053220 |
| Disease | Colon Cancer | Lung Non-Small Cell Carcinoma | Renal Cell Carcinoma |
| Altered gene | E1A|E1B |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | DNA oncolytic virus |
| Treatment | ColoAd1|Enadenotucirev |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase 1 Clinical Study of Intra-tumoural Injection or Intravenous Infusion of a Group B Oncolytic Adenovirus (ColoAd1) in Patients With Cancer Who Are Candidates for Resection of Primary Tumour |
| Year | 2013 |
| Country | Spain |
| Company sponsor | Akamis Bio |
| Other ID(s) | ColoAd1-1002 |
| Vector information | |||||||||
|
|||||||||
| Cohort1: intratumoral injection | |||||||
|
|||||||
| Cohort2: intravenous injection | |||||||
|
|||||||